Zoom remote conferencing application: AI training requires user authorization

Investing is booming, but capital alone isn’t enough. With valuations rising and distinctiveness fading, investors in AI-focused venture funds must make a key decision: Buy, build, or partner to gain an edge? Here’s how to evaluate each option—and pr

Let’s talk about it. This analysis of an innovative AI breakthrough is part of my ongoing Forbes column coverage on the latest in AI, including identifying and explaining various impactful AI complexities (see the link here). Heading Toward AGI And

Remember the flood of open-source Chinese models that disrupted the GenAI industry earlier this year? While DeepSeek took most of the headlines, Kimi K1.5 was one of the prominent names in the list. And the model was quite cool.

Let’s talk about it. This analysis of an innovative AI breakthrough is part of my ongoing Forbes column coverage on the latest in AI, including identifying and explaining various impactful AI complexities (see the link here). For those readers who h

By mid-2025, the AI “arms race” is heating up, and xAI and Anthropic have both released their flagship models, Grok 4 and Claude 4. These two models are at opposite ends of the design philosophy and deployment platform, yet they

For example, if you ask a model a question like: “what does (X) person do at (X) company?” you may see a reasoning chain that looks something like this, assuming the system knows how to retrieve the necessary information:Locating details about the co

The Senate voted 99-1 Tuesday morning to kill the moratorium after a last-minute uproar from advocacy groups, lawmakers and tens of thousands of Americans who saw it as a dangerous overreach. They didn’t stay quiet. The Senate listened.States Keep Th

Clinical trials are an enormous bottleneck in drug development, and Kim and Reddy thought the AI-enabled software they’d been building at Pi Health could help do them faster and cheaper by expanding the pool of potentially eligible patients. But the